GCP Applied Technologies Inc (GCP)

US36164Y1010 - Common Stock

32.01  +0.02 (+0.06%)

After market: 32.01 0 (0%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to GCP. GCP was compared to 84 industry peers in the Chemicals industry. GCP may be in some trouble as it scores bad on both profitability and health. GCP has a expensive valuation and it also scores bad on growth.



1

1. Profitability

1.1 Basic Checks

In the past year GCP was profitable.
In the past 5 years GCP has always been profitable.
In multiple years GCP reported negative operating cash flow during the last 5 years.

1.2 Ratios

Industry RankSector Rank
ROA 0.79%
ROE 1.71%
ROIC 4.2%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Industry RankSector Rank
OM 7.24%
PM (TTM) 1.1%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

3

2. Health

2.1 Basic Checks

GCP has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, GCP has more shares outstanding
Compared to 1 year ago, GCP has an improved debt to assets ratio.

2.2 Solvency

An Altman-Z score of 3.97 indicates that GCP is not in any danger for bankruptcy at the moment.
GCP has a Debt/Equity ratio of 0.54. This is a neutral value indicating GCP is somewhat dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.54
Debt/FCF N/A
Altman-Z 3.97
ROIC/WACC0.47
WACC8.96%

2.3 Liquidity

GCP has a Current Ratio of 3.93. This indicates that GCP is financially healthy and has no problem in meeting its short term obligations.
A Quick Ratio of 3.22 indicates that GCP has no problem at all paying its short term obligations.
Industry RankSector Rank
Current Ratio 3.93
Quick Ratio 3.22

3

3. Growth

3.1 Past

The earnings per share for GCP have decreased strongly by -41.86% in the last year.
GCP shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -22.25% yearly.
Looking at the last year, GCP shows a small growth in Revenue. The Revenue has grown by 3.34% in the last year.
The Revenue has been decreasing by -1.50% on average over the past years.
EPS 1Y (TTM)-41.86%
EPS 3Y-10.61%
EPS 5Y-22.25%
EPS growth Q2Q-31.82%
Revenue 1Y (TTM)3.34%
Revenue growth 3Y-4.83%
Revenue growth 5Y-1.5%
Revenue growth Q2Q5.92%

3.2 Future

The Earnings Per Share is expected to grow by 4.23% on average over the next years.
Based on estimates for the next years, GCP will show a small growth in Revenue. The Revenue will grow by 4.60% on average per year.
EPS Next Y-14.54%
EPS Next 2Y4.29%
EPS Next 3Y4.08%
EPS Next 5Y4.23%
Revenue Next Year6.93%
Revenue Next 2Y4.85%
Revenue Next 3Y4.51%
Revenue Next 5Y4.6%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

0

4. Valuation

4.1 Price/Earnings Ratio

GCP is valuated quite expensively with a Price/Earnings ratio of 64.02.
The average S&P500 Price/Earnings ratio is at 27.73. GCP is valued rather expensively when compared to this.
The Price/Forward Earnings ratio is 45.28, which means the current valuation is very expensive for GCP.
When comparing the Price/Forward Earnings ratio of GCP to the average of the S&P500 Index (20.41), we can say GCP is valued expensively.
Industry RankSector Rank
PE 64.02
Fwd PE 45.28

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 19.27

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y4.29%
EPS Next 3Y4.08%

0

5. Dividend

5.1 Amount

No dividends for GCP!.
Industry RankSector Rank
Dividend Yield N/A

GCP Applied Technologies Inc

NYSE:GCP (9/26/2022, 7:04:00 PM)

After market: 32.01 0 (0%)

32.01

+0.02 (+0.06%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap2.37B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 64.02
Fwd PE 45.28
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.79%
ROE 1.71%
ROCE
ROIC
ROICexc
ROICexgc
OM 7.24%
PM (TTM) 1.1%
GM N/A
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.72
Health
Industry RankSector Rank
Debt/Equity 0.54
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 3.93
Quick Ratio 3.22
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-41.86%
EPS 3Y-10.61%
EPS 5Y
EPS growth Q2Q
EPS Next Y-14.54%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)3.34%
Revenue growth 3Y-4.83%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y